Erik Lundgren insider trades

Open-market stock purchases and sales by Erik Lundgren, Chief Executive Officer at Immunic, Inc, from SEC Form 4 filings since May 22, 2026.

Recent trades

DateStockTradeValue
May 22, 2026IMUX Immunic, IncBought (not open market)—

Companies traded

  • IMUX Immunic, Inc: other filings, last May 22, 2026

Get free alerts when Erik Lundgren files a new trade →